Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Transcranial Photobiomodulation for Reducing Autism Symptoms in Children [NA]

View source ↗

Summary

This clinical trial evaluated transcranial photobiomodulation for reducing autism symptoms in children. Results were posted on 2024-05-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: JelikaLite LLC | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED | Results posted: 2024-05-16